Sleepease Liquid
NDC Package 61096-2001-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sleepease (aquilegia, avena, chamomilla, coffea cruda, cypripedium, humulus, kali phos, passiflora, valeriana, zinc met) liquids is temporarily relieves the common symptoms of sleeplessness, including:wakefulnessrestlessnessemotional stress and anxietycaffeine sensitivity. This formulation utilizes a liquid delivery system. Marketed by Eight & Company L.l.c, this product is identified by NDC 61096-2001.

Identification & Billing

NDC Package Code
61096-2001-1
Package Description
1 BOTTLE, SPRAY in 1 CARTON / 41 mL in 1 BOTTLE, SPRAY
Product Code
61096-2001
11-Digit Billing Format
61096200101

Clinical Specifications

Proprietary Name
Sleepease
Non-Proprietary Name
Aquilegia, Avena, Chamomilla, Coffea Cruda, Cypripedium, Humulus, Kali Phos, Passiflora, Valeriana, Zinc Met
Substance Name
Aquilegia Vulgaris; Arabica Coffee Bean; Avena Sativa Flowering Top; Cypripedium Parviflorum Var. Pubescens Root; Dibasic Potassium Phosphate; Hops; Matricaria Chamomilla Whole; Passiflora Incarnata Flowering Top; Valerian; Zinc
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Temporarily relieves the common symptoms of sleeplessness, including:wakefulnessrestlessnessemotional stress and anxietycaffeine sensitivity

Regulatory & Marketing

Labeler Name
Eight & Company L.l.c
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
04-24-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61096-2001-1 identifies a specific commercial package of 1 bottle, spray in 1 carton / 41 ml in 1 bottle, spray of Sleepease, a human over the counter drug labeled by Eight & Company L.l.c. This liquid is formulated for oral use and contains aquilegia vulgaris; arabica coffee bean; avena sativa flowering top; cypripedium parviflorum var. pubescens root; dibasic potassium phosphate; hops; matricaria chamomilla whole; passiflora incarnata flowering top; valerian; zinc as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eight & Company L.l.c on April 24, 2019. The current certification is valid through December 31, 2026.

How is this Eight & Company L.l.c product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61096200101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
61096-2001-1
11-Digit CMS (5-4-2)
61096-2001-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.